TheraCryf CEO Dr Huw Jones on Positive OX-1 Toxicology Results, Partner Interest & Human Trials

By London South East / May 15, 2026 / www.youtube.com / Article Link


TheraCryf plc (TCF) is a biotechnology company developing novel treatments for addiction and other neuropsychiatric disorders.

Recent News

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com

Newmont starts Q2/26 strong, growth expected for gold majors
July 27, 2026 / www.canadianminingreport.com

Gold not the consensus play anymore
July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year
July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities
July 14, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok